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Conclusions
•  Previous cases of bone marrow suppression related to COVID-19 include:
   33-year-old female patient who underwent extensive evaluation for 
myelodysplasias including bone marrow biopsy and ultimately received 
granulocyte colony-stimulating factor (G-CSF) for severe neutropenia 11 days 
following acute SARS-CoV-2 infection.6 
   5-month-old diagnosed with multisystem inflammatory syndrome in children 
(MIS-C) in the setting of 36-hour history of persistent fever, perineal cellulitis, 
and lip ulceration with a negative SARS-CoV-2 PCR but positive IgG and IgM 
was noted to have severe neutropenia treated with G-CSF.
   23-day-old and a 39-day-old neonate with mild COVID-19 were noted to have 
severe neutropenia that resolved without intervention.1 
•  Bone marrow suppression by well-known viruses could explain the 
hematological manifestations of SARS-CoV-2. 
•  Individuals with trisomy 21 are at increased risk of developing hematologic 
disturbances. 
   5-10% of infants with trisomy 21 develop transient myeloproliferative disease.12 
   Mutations in GATA 1 are well recognized in trisomy 21 to cause 
megakaryocyte and erythroid abnormalities but not myeloid.13 
•  Leukopenia, thrombocytopenia, and severe neutropenia remain novel findings. 
•  Bone marrow biopsy may not be indicated in patients with SARS-CoV-2 
infection and hematological abnormalities given the transient suppression of 
blood cell lines.
Introduction
•  Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
has been reported to cause a myriad of manifestations and complications. 
•  There are several documented cases of idiopathic thrombocytopenia purpura 
(ITP) as well as autoimmune hemolytic anemia (AIHA). 
•  Xu et al3 described the mechanism of thrombocytopenia related to COVID-19 as 
multifactorial including lung injury resulting in increased platelet consumption, 
direct infection of bone marrow stromal cells, and cytokine storm resulting in 
destruction of bone marrow progenitor cells. 
•  There are documented cases of lymphopenia secondary to proposed 
lymphocyte apoptosis during inflammatory storms.4 
•  Two cases of severe neutropenia in neonates have been reported by Venturini  
et al5 in association with mild COVID-19. 
Case Description  
•  17-year-old female with a history of trisomy 21, aortic insufficiency, celiac disease, 
and obesity 
•  Transferred with complaints of dehydration, fever, diarrhea, and a recent, known 
household member positive for SARS-CoV-2 
•  5-day history of fever, lethargy, mucopurulent nasal secretions, reduced oral 
intake, and decreased urine output prior to admission 
admission vital signs
Temp Pulse Resp BP SpO2 BMI
99.4 °F 102 20 98/82 97% 34.73
admission laboratory findings
  
Absolute neutrophil count: 351




Figure 1: Chest radiography revealed bilateral 





•  Placed on empiric antibiotics secondary to severe neutropenia
•  Nasopharyngeal swab detected SARS-CoV-2
•  Developed hypoxemia requiring escalation of care to our pediatric intensive care 
unit and high flow oxygen therapy was initiated
•  Corticosteroids and antiviral (remdesivir) initiated 
hospital day 3  
laboratory findings 
  
Absolute neutrophil count: 798
•  Hospital day 5 transferred to general 
pediatrics floor and weaned off  
oxygen support
•  Discharged home the following day 
once tolerating room air 
one month later outpatient 
laboratory findings 
  
Absolute neutrophil count: 1,568
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